Transcript
  • HIVSource: Prous Investigator Portal

  • HIV20081078000Source: Prous Investegator Portal)

  • HIV Source: Prous Investegator Portal)

  • HIV Source: Prous Investegator Portal)

  • HIV Source: Derwent Innovations Index)

  • HIV Source: Delphion)

  • HIV8000Source: Prous Investegator Portal)

  • HIVSource: Thomson Pharma)

  • HIVSource: Thomson Pharma)

  • HIV119103Gilead Sciences IncTruvada 200820Source: Thomson Pharma)

  • 2006-2008Gilead Sciences IncAtripla2007830Source: Thomson Pharma)

  • HIVTruvadaSource: Thomson Pharma)

  • HIVHIV/Source: Thomson Pharma)

  • HIV8000Source: Prous Investegator Portal)

  • IIIElvitegravirSource: Prous Investegator Portal)

  • ElvitegravirSource: Prous Investegator Portal)

  • ElvitegravirSource: Prous Investegator Portal)

  • Elvitegravir/Source: Prous Investegator Portal)

  • ElvitegravirSource: Prous Investegator Portal)

  • HIVSource: Prous Investegator Portal)

  • HIVSource: Prous Investegator Portal)

  • HIV

  • 1983Barresinoussi FHIV

    Science, Volume:220; Issue:4599; Pages868-871Published: 1983

    4390 2008107

  • ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) Science, Volume:220; Issue:4599; Pages868-871Published: 1983


Top Related